B-Cell Cancers: Sparse Insight Into Preventing Infections :

"We simply don't know" which preventive strategy is most effective, says expert. Patients will survive their cancers and "be at risk of infection or have significant cytopenias," she warned.

Related Keywords

Melbourne , Victoria , Australia , Ottawa , Ontario , Canada , Wellington , New Zealand General , New Zealand , Monash , South Australia , Zoe Mcquilten , Juthaporn Cowan , Robert Weinkove , Malaghan Institute Of Medical Research , National Blood Authority , Astrazeneca , University Of Ottawa , Glaxosmithkline , Monash University , Blood Advances , Malaghan Institute , Medical Research , National Blood , Chronic Lymphocytic Leukemia , Riga , Otolaryngology , Nt Ears , Nose , Throat , Biologic Therapy , Cancer , Alignant Neoplasia , Arcinoma , Cancer Risk , Intravenous Immunoglobulin , Targeted Therapy , Antibiotics , Igecycline , Immunizations , Vaccination , Hypogammaglobulinemia , Chimeric Antigen Receptort Cell Therapy , Chimeric Antigen Receptors , Himeric Immunoreceptors , Himerict Cell Receptors , Rtificialt Cell ,